HOMVOH INFUSION (mirikizumab, IV induction) Patient Assistance Program
Don’t let the high cost of brand specialty IBD biologics stand between you and the treatment you need. We help eligible patients access Omvoh Infusion (mirikizumab, IV induction) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Omvoh Infusion (mirikizumab IV) is FDA-approved as the induction therapy for moderately-to-severely active ulcerative colitis (UC) in adults and for moderately-to-severely active Crohn's disease in adults. It is given as IV infusions at Weeks 0, 4, and 8.
- Without assistance, each Omvoh IV induction infusion commonly costs approximately $15,000–$20,000, with the full three-dose induction course totaling $45,000–$60,000.
- Through AffordMyPrescriptions, qualifying patients can access Omvoh Infusion for a flat $69.95 per month — our advocacy team manages the entire enrollment, infusions, and renewal process.
- There is no biosimilar version of Omvoh available in the U.S. as of 2026. Patients typically transition from the IV induction phase to the subcutaneous Omvoh Injection for maintenance therapy.
What Is Omvoh Infusion Prescription Assistance Program?
The Omvoh Infusion Prescription Assistance Program is a manufacturer-sponsored initiative that provides Omvoh IV induction at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for IBD patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, gastroenterology coordination, prior-authorization documentation, infusion-center scheduling, and the transition to subcutaneous maintenance therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through induction infusion scheduling and the eventual transition to maintenance dosing — so you focus on your health, not paperwork.
Pharmacy Price Comparison
- Without assistance, Omvoh Infusion costs roughly $15,000–$20,000 per IV induction dose. Pharmacy discount coupons are not a meaningful tool for IV therapy. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Per IV induction dose | ~$17,500.00 | Save ~$17,430/dose |
| Week 0 induction | ~$17,500.00 | Save ~$17,430/dose |
| Week 4 induction | ~$17,500.00 | Save ~$17,430/dose |
| Week 8 induction | ~$17,500.00 | Save ~$17,430/dose |
| Full induction course | ~$52,500.00 | Save ~$52,430 total |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Omvoh Infusion Prescription Program?
The Patient Assistance Program is free to apply for and provides Omvoh Infusion at no medication cost if approved. But the process involves detailed applications, gastroenterology coordination, prior-authorization documentation, infusion scheduling, and the transition to subcutaneous maintenance therapy. Our $69.95/month service covers full advocacy: applications, doctor coordination, infusion scheduling, transition coordination, and annual re-enrollment.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Omvoh Infusion:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $15,000–$20,000 per induction dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Omvoh Infusion assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Omvoh Infusion Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Omvoh Infusion:
Omvoh Infusion (mirikizumab) is the intravenous induction phase of an IL-23 inhibitor biologic used to treat moderately-to-severely active ulcerative colitis and moderately-to-severely active Crohn’s disease in adults. Treatment begins with three IV induction infusions at Weeks 0, 4, and 8, after which patients transition to the subcutaneous Omvoh Injection for ongoing maintenance therapy.
How Omvoh Infusion:
Omvoh is a monoclonal antibody designed to treat inflammatory bowel diseases like ulcerative colitis and Crohn’s disease by targeting the IL-23 cytokine. By selectively binding to the p19 subunit of IL-23, it blocks the signaling that drives chronic intestinal inflammation and bowel damage. This process dampens the overactive immune response, helping to reduce symptoms such as abdominal pain and diarrhea while working to induce and sustain remission.
Form and use:
The treatment begins with an induction phase consisting of three 300 mg IV infusions administered at Week 0, Week 4, and Week 8 in a clinical setting. Each infusion typically takes about 30 minutes to complete. Following this initial period, patients transition to a subcutaneous injection format starting at Week 12 for their ongoing maintenance therapy.
Generic availability:
As of 2026, there is no biosimilar version of Omvoh available in the United States. While other IL-23 inhibitors like Skyrizi exist, patients also have access to various other biologics, including TNF inhibitors and IL-12/23 inhibitors, some of which do have biosimilar options. The specific choice of therapy depends on the individual’s condition and prior treatment history.
Warnings:
Omvoh carries risks of serious infections, including the potential reactivation of latent tuberculosis, making TB screening a standard requirement before starting treatment. Other important warnings include the risk of liver injury (hepatotoxicity) and hypersensitivity reactions. Patients should avoid live vaccines while on this medication and promptly report symptoms like fever, jaundice, or unusual fatigue to their gastroenterologist.
FAQ (Frequently Asked Questions)
How Much Does Omvoh Infusion Cost Without Insurance?
Each IV induction dose commonly costs $15,000–$20,000, with the full three-dose induction course totaling $45,000–$60,000. Through AffordMyPrescriptions, qualifying patients receive Omvoh Infusion at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Omvoh Infusion Given?
Omvoh Infusion is given as a 30-minute IV infusion in a clinic, infusion center, or hospital outpatient setting. The dose is 300 mg administered at Week 0, Week 4, and Week 8 (induction phase). After Week 12, patients transition to subcutaneous Omvoh Injection for ongoing maintenance therapy.
What Happens After The Induction Phase?
After the three-dose IV induction phase (Weeks 0, 4, 8), patients transition to subcutaneous Omvoh Injection for ongoing maintenance therapy. The subcutaneous form is given at home and provides convenient long-term dosing.
Are There Other IBD Biologics I Should Know About?
Yes. Other options include risankizumab (Skyrizi, also IL-23), TNF inhibitors with biosimilars (adalimumab/Humira, infliximab/Remicade), integrin inhibitors (vedolizumab), IL-12/23 inhibitors (ustekinumab/Stelara, with biosimilars), JAK inhibitors (upadacitinib, tofacitinib), and S1P modulators (ozanimod). Whether one is a better clinical fit depends on prior treatments and tolerability. We mention this directly because if a different therapy on a more accessible assistance pathway would work, that may be a better path.
Can I Get Omvoh Through The PAP If I Have Medicare?
Unopened Humulin N vials and pens should be stored in the refrigerator until the expiration date. Once in use, vials and pens can be kept at room temperature (below 86°F/30°C) for up to 31 days. Do not freeze, and do not expose to direct sunlight or heat. Vials must be gently rolled (not shaken) before each dose to resuspend the cloudy formulation.
What If My Application Is Denied?
Yes. Medicare beneficiaries can typically qualify for Omvoh Patient Assistance, especially if you face significant out-of-pocket costs under medical or pharmacy benefits. The manufacturer’s commercial copay assistance program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
Take Control of Your Medication Costs
If you are struggling with the high cost of Omvoh Infusion induction therapy, our team may be able to help you access assistance programs designed to make brand specialty IBD biologics affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.